Jiwu Wang

This inventor holds 15 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Allele Biotechnology & Pharmaceuticals, Inc., University of Alberta. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiwu Wang. Retrieved from https://idiyas.com/inventor/jiwu-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 8)

% Patents Active = 86.7

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 70(Granted Patents)

Location History:

San Diego, CA (US) (2007 - 2009)
La Jolla, CA (US) (2015 - 2020)

Company Filing History:

15 out of 15

Allele Biotechnology & Pharmaceuticals, Inc.

patents

1 out of 455

University of Alberta

patents

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559729 - Induction of hepatocytes by stem cell differentiation with RNA (2026-02-24),

2. 12404552 - Methods of selecting antibodies and antibody fragments (2025-09-02),

3. 12338462 - Induction of pancreatic beta cells by stem cell differentiation with RNA (2025-06-24),

4. 12104171 - Induction of neural progenitor cells, oligodendrocyte progenitor cells, and oligodendrocytes by stem cell differentiation using landmark transcription factors (2024-10-01),

5. 10842728 - Light-absorbing compositions and methods of use (2020-11-24),

6. 10435711 - Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA (2019-10-08),

7. 10221221 - Monomeric yellow-green fluorescent protein from cephalochordate (2019-03-05),

8. 10155929 - Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA (2018-12-18),

9. 10119150 - Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA (2018-11-06),

10. 9737472 - Light-absorbing compositions and methods of use (2017-08-22),

11. 9205284 - Light-absorbing compositions and methods of use (2015-12-08),

12. 9145447 - Photoconvertible fluorescent proteins (2015-09-29),

13. 7625750 - Compositions for DNA mediated gene silencing (2009-12-01),

14. 7422896 - Compositions for DNA mediated gene silencing (2008-09-09),

15. 7294504 - Methods and compositions for DNA mediated gene silencing (2007-11-13),

Title: The Innovative Contributions of Jiwu Wang

Introduction

Jiwu Wang is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of methods for antibody selection and stem cell differentiation. With a total of 15 patents to his name, Wang's work has the potential to impact various areas of medical research and treatment.

Latest Patents

One of Wang's latest patents is focused on methods of selecting antibodies and antibody fragments. This multi-step method enhances the efficiency of finding antibodies against specific immunogens. The technology not only improves the selection process but also ensures that the antibodies or fragments represent the most abundant antibodies induced by the immunogen, thereby maximizing specificity and affinity. This invention has utility in numerous fields that involve antibody or T cell receptor selection.

Another notable patent involves the induction of pancreatic beta cells through stem cell differentiation using RNA. This innovative method allows for the production of pancreatic beta cells from human induced pluripotent stem cells with unprecedented efficiency and functionality. The core of this invention lies in the use of experimentally discovered mRNAs at critical differentiation decision points, facilitating the transition from pluripotent stem cells to functional pancreatic beta cells.

Career Highlights

Throughout his career, Jiwu Wang has worked with several notable organizations, including Allele Biotechnology & Pharmaceuticals, Inc. and the University of Alberta. His experience in these institutions has contributed to his expertise in biotechnology and innovation.

Collaborations

Wang has collaborated with talented individuals such as Yuhui Ni and Yuanyuan Zhao. These partnerships have likely enriched his research and development efforts, leading to groundbreaking advancements in his field.

Conclusion

Jiwu Wang's innovative contributions to biotechnology, particularly in antibody selection and stem cell differentiation, highlight his role as a leading inventor. His patents reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.